Jnana Therapeutics - Ownership and Business Overview

Life ScienceCompany

Jnana Therapeutics Ownership

Who owns Jnana Therapeutics?

Jnana Therapeutics is owned by Otsuka Pharmaceutical. It was acquired on August 1, 2024.

Was Jnana Therapeutics formerly PE-backed?

Yes. Jnana Therapeutics was formerly owned by 1 private investor.

Jnana Therapeutics Business Overview

Where is Jnana Therapeutics headquartered?

Jnana Therapeutics is headquartered in Boston, Massachusetts.

What sector is Jnana Therapeutics in?

Jnana Therapeutics is a life science company.

When was Jnana Therapeutics founded?

Jnana Therapeutics was founded in 2017.

Life Science M&A Summary in 2024

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2024. The largest life science acquisition in 2024 was Catalent - which was acquired by Novo Holdings A/S for $16.5B.

Join Mergr to view all 186 acquisitions of life science companies in 2024, including 14 acquisitions by private equity firms, and 172 by strategics.

Jnana Therapeutics

Jnana Therapeutics, Inc.

One Design Center Place, Suite 19-400,
Boston, Massachusetts 02210
United States,
(857) 349-9200
www.jnanatx.com

Jnana Therapeutics is developing drugs against a broad family of metabolite transport proteins to treat high unmet needs in auto-immune, immuno-metabolism, and other diseases. Jnana Therapeutics was founded in 2017 and is based in Boston, Massachuserrs.


 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.